Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2731-2740 of 2873 for cancer

Edit search filters
  1. A Study Of The Quality Of Life After Surgery For Recurrent Rectal Cancer

    Rochester, MN

  2. A Study Of Astrin Biosciences EV-based Proteomic Assay In Detecting Breast Cancer

    Rochester, MN

  3. Acceptability Of Testing DNA Markers In Vaginal Fluid For The Detection Of Endometrial Cancer

    Rochester, MN

  4. A Study To Evaluate Cancer Patients' Experience With Bevacizumab- Induced, Wound-healing Complications

    Rochester, MN

  5. Assessing Vitamin D And Mammogram Density As Biomarkers Of Breast Cancer In Olmsted County

    Rochester, MN

  6. Survey Study On Patient Reported Outcomes For Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. A Study Of Broadband Quality On Video Visits Among Mayo Clinic Cancer Patients

    Eau Claire, WI, Rochester, MN

  8. Efficacy And Safety Of Treatment With Alpelisib Plus Endocrine Therapy In Patients With HR+, HER2-negative ABC, With PIK3CA Mutations, Whose Disease Has Progressed On Or After CDK 4/6 Treatment With An Aromatase Inhibitor (AI) Or Fulvestrant

    Scottsdale/Phoenix, AZ

  9. Gene Expression In Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Of Diagnostics And New Sequencing Technologies In Cancer Genetics

    Rochester, MN

.

Mayo Clinic Footer